Catalyst Wire Dossier Catalyst Wire Dossier

Plasma exchange with 5% albumin

· Instituto Grifols, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Plasma exchange with 5% albumin, covering 2016-06-14 to 2016-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid [Phase 2]

See pricing